BAKER Bros. Advisors L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 270,006 shares at $76.57 ($20.1M) on 2019-03-15, disclosed to the SEC on 2019-03-19.
Open-market sale of $20.1M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.50 | 647 | $48K | 0.2% |
| 2 | $74.50 | 722 | $54K | 0.3% |
| 3 | $74.50 | 1,115 | $83K | 0.4% |
| 4 | $74.50 | 49 | $4K | 0.0% |
| 5 | $74.50 | 6,467 | $482K | 2.4% |
| 6 | $74.50 | 42,124 |
| $3.1M |
| 15.6% |
| 7 | $74.56 | 7 | $522 | 0.0% |
| 8 | $74.56 | 63 | $5K | 0.0% |
| 9 | $74.56 | 11 | $820 | 0.0% |
| 10 | $74.56 | 413 | $31K | 0.2% |
| 11 | $74.56 | 6 | $447 | 0.0% |
| 12 | $76.57 | 4 | $306 | 0.0% |
| 13 | $76.57 | 47 | $4K | 0.0% |
| 14 | $76.57 | 52 | $4K | 0.0% |
| 15 | $76.57 | 81 | $6K | 0.0% |
| 16 | $76.57 | 471 | $36K | 0.2% |
| 17 | $76.57 | 3,068 | $235K | 1.2% |
| 18 | $74.19 | 106 | $8K | 0.0% |
| 19 | $74.19 | 1,385 | $103K | 0.5% |
| 20 | $74.19 | 1,547 | $115K | 0.6% |
| 21 | $74.19 | 2,388 | $177K | 0.9% |
| 22 | $74.19 | 13,856 | $1.0M | 5.1% |
| 23 | $74.19 | 90,251 | $6.7M | 33.3% |
| 24 | $74.63 | 101 | $8K | 0.0% |
| 25 | $74.63 | 1,329 | $99K | 0.5% |
| 26 | $74.63 | 1,485 | $111K | 0.6% |
| 27 | $74.63 | 2,293 | $171K | 0.9% |
| 28 | $74.63 | 13,298 | $992K | 4.9% |
| 29 | $74.63 | 86,620 | $6.5M | 32.2% |
| Total | $74.45 avg | 270,006 | $20.1M | 100% |
| Filing → |
| IGMS | BUY | 2024-03-28 | $6.8M | — | Filing → |
| MDGL | BUY | 2023-12-14 | $45.0M | — | Filing → |
| TRDA | BUY | 2022-05-24 | $396K | — | Filing → |